You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

U.S. names HIV, arthritis drugs for next Medicare price talks ○

found 2026 › Jan › 28 (Wed) @ 06:36 UTC

US ■■■■
Medicare ■■
Gilead Sciences ■■
Biktarvy ■■
Pfizer ■■
Xeljanz ■■

The U.S. government on Tuesday named the 15 new drugs targeted for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug Biktarvy and Pfizer's arthritis treatment Xeljanz.